NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

市场调查报告书

体外式薄膜型人工肺(ECMO)设备(心血管)-全球市场分析及预测模式(COVID-19对市场造成的影响)

Extracorporeal Membrane Oxygenation (ECMO) Devices (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 market impact)

出版商 GlobalData 商品编码 979414
出版日期 内容资讯 英文
订单完成后即时交付
价格
体外式薄膜型人工肺(ECMO)设备(心血管)-全球市场分析及预测模式(COVID-19对市场造成的影响) Extracorporeal Membrane Oxygenation (ECMO) Devices (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 market impact)
出版日期: 2020年08月30日内容资讯: 英文
简介

本报告详细探讨体外膜氧合装置用于治疗心肌梗死,心力衰竭,心源性休克,先天性心脏病和急性呼吸窘迫综合征的方法。由于肺部,心脏或两者的并发症,此类患者发展出无法适当地为其血液充氧的功能。

将静脉插管插入颈静脉或股静脉,以从上/下腔静脉排出静脉血,并将含氧的血液返回至右心房。将动脉套管插入主动脉或股动脉以绕过心脏和肺部,并从ECMO机将含氧血液返回到动脉系统中。氧合器用于在返回心脏或动脉系统之前,通过去除CO2并给静脉血氧合来代替肺部的作用。泵用于管理静脉血的排出,通过充氧器的流量以及返回充氧血液的流量。

本报告提供体外式薄膜型人工肺(ECMO)设备市场相关调查,提供市场概要,以及2015~2030年的市场预测,各市场区隔,各国的趋势等资讯。

  • 主要的产业趋势洞察
  • 2015年~2030年各分类市场预测
  • 手术数量,台数,平均销售价格,各分类市场价值相关详细资料

全球地区,各国趋势

  • 各国分析
  • SWOT分析
  • 竞争趋势

健康护理系统概要

  • 医疗保健制度的各国概要
  • 各国给付方针
  • 国家固有的医疗技术相关法规趋势

网罗的企业:GetingeUSA Inc(MAQUET),Terumo Corp,ALung Technologies,LivaNova plc(Sorin Group),Medtronic plc,MicroPort Scientific Corporation,Eurosets Srl,OriGen Biomedical Inc,Fresenius Medical Care Group(Xenios AG),其他

觀察对象国家:美国,英国,德国,法国,义大利,西班牙,巴西,中国,印度,俄罗斯,日本,澳洲,加拿大,墨西哥,韩国,丹麦,爱尔兰,荷兰,纽西兰,南非,瑞典,瑞士,奥地利,比利时,芬兰,以色列,挪威,波兰葡萄牙,台灣,捷克,希腊,匈牙利,土耳其,埃及,沙乌地阿拉伯,阿拉伯联合大公国,阿根廷,智利

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: GDME712MM

Extracorporeal Membrane Oxygenation (ECMO) Devices (Cardiovascular) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within Cardiovascular therapeutic area.

The model discusses the use of Extracorporeal Membrane Oxygenation Devices are used to treat Myocardial Infraction, Heart Failure, Cardiogenic Shock, Congenital Heart Disease and Acute Respiratory Distress Syndrome. Such patients develop the inability to properly oxygenate their blood, due to complications of the lung, heart, or both.

Venous Cannulae are inserted into the jugular vein or the femoral vein to drain venous blood from the superior/inferior vena cava and returning oxygenated blood to the right atrium. Arterial cannulae are inserted into the aortic artery or the femoral artery to bypass the heart and lungs and return oxygenated blood into the arterial system from the ECMO machine. Oxygenators are used to replace the role of lungs by removing CO2 and oxygenating venous blood prior to being returned to the heart or arterial system. Pumps are used to manage the drainage of venous blood, flow rate through the oxygenator, and flow rate for returning oxygenated blood.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed ECMO market and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total ECMO market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for ECMO market.
  • Competitive dynamics insights and trends provided ECMO market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Getinge USA Inc (MAQUET), Terumo Corp, ALung Technologies, LivaNova plc (Sorin Group), Medtronic plc, MicroPort Scientific Corporation, Eurosets Srl, OriGen Biomedical Inc, Fresenius Medical Care Group (Xenios AG), and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

Who should buy this report?

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the ECMO marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Who should buy this report?

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the ECMO marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on ECMO market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving ECMO market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the ECMO market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific ECMO market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.